Roche to Invest $7.1 Billion in Game-Changing Inflammatory Disease Treatment
Swiss healthcare leader, Roche, is making waves with a $7.1 billion deal to acquire Telavant Holdings, a key player in ...
© 2020 ImpactWealth
Tag: Immunology
Swiss healthcare leader, Roche, is making waves with a $7.1 billion deal to acquire Telavant Holdings, a key player in ...
